UK increases COVID-19 vaccine manufacturing capacity

Pharma Times

4 August 2020 - The UK government has signed a new deal with biotech organisation Wockhardt to increase the manufacturing capacity for COVID-19 vaccines.

The UK has entered into an 18-month agreement with Wockhardt to carry out the crucial ‘fill and finish’ stage of the manufacturing process. This includes dispensing the manufactured vaccines substance into vials for distribution.

According to a statement released by the UK government yesterday, this aspect of the manufacturing process is expect to begin in September 2020.

Read Pharma Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

England , Vaccine , Supply , COVID-19